Steinar J. Engelsen - 01 Nov 2021 Form 4 Insider Report for INSMED Inc (INSM)

Reporting relationship: Director
Issuer ticker: INSM
Reported as of: 01 Nov 2021
Net transaction value: +$429,043
SEC form: 4
Accepted by SEC: 03 Nov 2021, 16:26:44 UTC
Prior SEC filing: 14 May 2021
Source filing: View source filing
Reporting owner signature: /s/ Steinar Engelsen, M.D., by Michael Smith as Attorney-in-fact

Key filing fact

Steinar J. Engelsen filed Form 4 for INSMED Inc (INSM) on 03 Nov 2021.

Key facts

This page summarizes Steinar J. Engelsen's Form 4 filing for INSMED Inc (INSM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 03 Nov 2021, 16:26.

Change

Previous filing in this sequence was filed on 14 May 2021.
Current net transaction value: +$429,043.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

INSM transaction

Common Stock

Purchase

Transaction value: $429,043
Shares: +14,235
Change %: +4.6%
Price: $30.14
Shares after: 320,802
Date: 01 Nov 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This is the weighted average sales price representing the shares purchased at prices ranging from $30.05 to $30.25 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares purchased at each price within the price range upon request.